![Pei Ling Tsai](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Pei Ling Tsai
Corporate Officer/Principal at CytoPharm, Inc.
Profile
Pei Ling Tsai is currently working as a Commission-Clinical Studies at CytoPharm, Inc. She completed her undergraduate degree from National Yang Ming University.
Pei Ling Tsai active positions
Companies | Position | Start |
---|---|---|
CytoPharm, Inc.
![]() CytoPharm, Inc. Pharmaceuticals: MajorHealth Technology CytoPharm, Inc. engages in the biopharmaceutical industry. The company specializes in protein drug development. It focuses on producing human natural cytokines such as interferon, interleukin and chemokine as modulators of human immune system. The products can be utilized in single or cocktail treatment model for chronic virus hepatitis, various oncology diseases, virus infection and autoimmune diseases. The company was founded on February 12, 2003 and is headquartered in Taipei, Taiwan. | Corporate Officer/Principal | 22/09/2011 |
Training of Pei Ling Tsai
National Yang Ming University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
CytoPharm, Inc.
![]() CytoPharm, Inc. Pharmaceuticals: MajorHealth Technology CytoPharm, Inc. engages in the biopharmaceutical industry. The company specializes in protein drug development. It focuses on producing human natural cytokines such as interferon, interleukin and chemokine as modulators of human immune system. The products can be utilized in single or cocktail treatment model for chronic virus hepatitis, various oncology diseases, virus infection and autoimmune diseases. The company was founded on February 12, 2003 and is headquartered in Taipei, Taiwan. | Health Technology |
- Stock Market
- Insiders
- Pei Ling Tsai